TrialLancet (London, England)2019

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Maura L Gillison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.